Top 50 Most Viewed Posts Last Month |
Today This Week Last Week This Month Last Month
|
1. Rosner: Short Interest Report As of Sat, Aug 3, '13 (7965) |
2. MGK_2: So, in the experiment, they took 4 monkeys (3979) (14) |
3. KenChowder: I may not be reading the abstract right. Yes, (3676) (13) |
4. Jake2212: Sean: Perhaps because Michelle Kilcoyne left CYDY (3044) (18) |
5. MJS719: Thank you brentie for the reminder of how (2800) (10) |
6. Cycl2R: I don’t believe it has been noted here that the (2782) (12) |
7. ohm20: Got a crazy question, but what do you think about (2088) (21) |
8. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (1538) |
9. ohm20: Regarding posting my scientific posts from here (1478) (11) |
10. MGK_2: ohm, as you know, most of us Greatly value your (1402) (6) |
11. Respert24: Hey Sherlock, Another nice post. I agree about (1311) (32) |
12. Katangolo: Dr. J and the Team have been keeping their cards (1200) (40) |
13. Jake2212: Is Gilead seriously in play to invest in LL for (1167) (41) |
14. Respert24: Good post, Sherlock57. I wanted to give some (1151) (43) |
15. MJS719: Happy New Year to all. Just saw this and wanted (1071) (13) |
16. MGK_2: I put together this analysis on the human mTNBC (1008) (27) |
17. sherlock57: Kat--Appreciate your post on the "radio silence." (926) (28) |
18. Riztheinvestor: I was just talking about this so I’ll share it (893) (20) |
19. ohm20: would a Phase III that repeats the Phase II be (860) (13) |
20. Katangolo: We all can have our preferences on who we would (856) (26) |
21. Boatbuilder: Agreed. There was a time I’d see a 100% return (799) (10) |
22. dfwl28: Thanks, My69z. Excellent (783) (1) |
23. dfwl28: Thanks Katangolo. It is very helpful towards a (769) (1) |
24. Ramjet: Agreed and well said. Let me just add that I'm (761) (8) |
25. sean007: I was told by a former Gilead scientist...Do Not (758) (10) |
26. Respert24: Another good post. You wrote: "But at the risk of (751) (27) |
27. sherlock57: Appreciate the responses Respert24 and Plotinus. (751) (27) |
28. mountaineer: Someone else noticed: "Published on February 20, (751) |
29. dfwl28: The current CEO used to handle such requests. I (744) (4) |
30. Niele: Finally got it done. Several posters here have (738) (10) |
31. My69z: Exactly & hopefully news outlets will start (730) (5) |
32. Respert24: It's truly impossible for a family or internal (729) (15) |
33. My69z: Try link again -- I test before posts so don't (728) (7) |
34. skipper1072: From Reddit (r/Livimmune): r/Livimmune • 4 days (719) (5) |
35. My69z: mTNBC timeline to Cure: Sept. 9th, 2024 Letter. I (716) (16) |
36. Cycl2R: This explains our no show at the MASH conference. (715) (10) |
37. Evil Rabbit: https://www.targetedonc.com/view/leronlimab-gets- (715) (25) |
38. Respert24: Respert24’s Guide To Remaining Hopeful For (715) (16) |
39. Evil Rabbit: Yeah it’s a new article of months-old news. But (713) (3) |
40. sherlock57: I'm not surprised by the MASH news either. In (706) (16) |
41. Wharfrat: Dream Exchange Holdings, Inc.; Notice of Filing (704) (12) |
42. Stratego: Our CEO Dr. Lalezari was honored as a (703) (11) |
43. misiu143: Some cancer /tumor cells may not express CCR5 , (693) (14) |
44. Jake13: $CBT Cabot Corp 55.72 Had 59,859 1 Month Highs. (691) |
45. Mr3Putt: I posted this factoid from a few days back: (686) (10) |
46. biloxiblues: My reply to the post on Reddit (684) (12) |
47. smach: The website being down is a positive sign looked (683) (8) |
48. Katangolo: Looks like the clock has started. Hope we get to (681) (1) |
49. docj: From Fidelity: McLean Capital Management resumes (679) (8) |
50. seemingly-harmless: more than half of the 26 women from the trial (678) (14) |